tradingkey.logo
tradingkey.logo
Search

Jin Medical International Ltd

ZJYL
Add to Watchlist
2.060USD
+0.090+4.57%
Close 07-30 16:00ETQuotes delayed by 15 min
16.12MMarket Cap
179.91P/E TTM

ZJYL Cash Flow Statement

You can access the annual and quarterly cash flow statements of Jin Medical International Ltd to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-446.45%-1.26M
-98.18%50.00K
--362.91K
--2.74M
Net income from continuing operations
54.28%1.72M
-3.51%1.70M
--1.11M
--1.77M
Operating gains losses
59.71%177.98K
46.90%168.15K
--111.44K
--114.47K
Deferred tax
-40.03%12.62K
-65.42%23.71K
--21.04K
--68.56K
Other non-cash items
113.22%6.77K
-157.88%-99.28K
---51.19K
--171.52K
Change in working capital
-285.24%-3.17M
-381.25%-1.75M
---822.88K
--622.08K
-Change in receivables
-960.68%-2.88M
-882.52%-1.02M
---271.79K
---104.29K
-Change in inventory
-143.88%-486.42K
26.78%566.73K
--1.11M
--447.02K
-Change in prepaid expenses
92.89%-54.32K
-2854.35%-1.31M
---763.86K
--47.50K
-Change in payables and accrued expense
-183.61%-109.21K
806.93%206.42K
---38.51K
---29.20K
-Change in other current assets
----
----
----
--0.00
-Change in other current liabilities
-49.73%96.23K
6.54%-159.98K
--191.43K
---171.17K
Cash from non-recurring investing activities
Cash from operating activities
-446.45%-1.26M
-98.18%50.00K
--362.91K
--2.74M
Investing cash flow
Net cash from continuing investing activities
-35.55%59.86K
9649.17%1.06M
--92.89K
--10.91K
Capital expenditures
-40.47%61.27K
9563.81%1.06M
--102.92K
--11.01K
Net cash flow from disposal of fixed assets
-35.55%59.86K
9649.17%1.06M
--92.89K
--10.91K
Net cash flow from investment products
80.00%-1.06M
-218.15%-7.33M
---5.32M
---2.30M
Net cash flow from other investing activities
-189.07%-4.24M
189.07%4.24M
--4.76M
---4.76M
Cash from non-current investing activities
Net cash flow from investing activities
-717.28%-5.36M
41.34%-4.15M
---656.42K
---7.07M
Financing cash flow
Cash flow from continuous financing activities
575.09%5.65M
-25.87%6.00M
---1.19M
--8.10M
Net cash flow from debt Issuance/repayment
-53.47%1.31M
287.58%5.55M
--2.82M
--1.43M
Net cash flow from common stock issuance/repurchase
--0.00
-96.10%312.00K
--0.00
--8.00M
Net cash flow from preferred stock issuance/repurchase
----
100.00%0.00
--0.00
---1.21M
Proceeds from stock option exercised by employees
----
----
--336.64K
----
Net cash flow from other financing activities
199.78%4.34M
214.87%138.22K
---4.35M
---120.33K
Net cash from non-recurrent financing activities
Net cash from financing activities
575.09%5.65M
-25.87%6.00M
---1.19M
--8.10M
Net cash flow
Beginning cash balance
2.20%8.87M
44.59%6.93M
--8.68M
--4.79M
Current period cash flow changes
57.90%-738.72K
-50.01%1.95M
---1.75M
--3.89M
Effect of exchange rate changes
185.80%233.29K
-66.94%40.34K
---271.90K
--122.00K
Ending cash balance
17.41%8.14M
2.20%8.87M
--6.93M
--8.68M
Free cash flow
-607.17%-1.32M
-137.12%-1.01M
--259.99K
--2.73M
Currency unit
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Jin Medical International Ltd Generate?

Jin Medical International Ltd generated 2.90M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Jin Medical International Ltd's Operating Cash Flow Change Year Over Year?

Jin Medical International Ltd's operating cash flow increased by 340.50% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Jin Medical International Ltd Spend on Capital Expenditures?

Jin Medical International Ltd spent 6.63M on capital expenditures in the most recent quarter。

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Jin Medical International Ltd's Financing Cash Flow Changed?

Jin Medical International Ltd used 7.35M in financing activities in the latest quarter.

What is free cash flow and why does it matter for ZJYL?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Jin Medical International Ltd’s free cash flow in the latest quarter?

Free cash flow was -3.73M reflecting a -59.82% change from the previous year.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.